00:38 , Jun 21, 2019 |  BC Innovations  |  Tools & Techniques

A human CRISPR-like system adds a new approach to regulating translation

A new system modeled on CRISPR and made entirely of human proteins is the latest strategy to intervene in gene control at the RNA translation level. The technology could bring higher levels of precision and...
00:28 , May 24, 2019 |  BC Innovations  |  Emerging Company Profile

Anima opens new target space in translational control

Anima Biotech’s answer to undruggable targets is to go after the machinery that turns their mRNA into protein, adding a new approach to the gene regulation tool kit. The strategy should give Anima a leg...
15:36 , Jul 27, 2018 |  BC Week In Review  |  Company News

Lilly pairs up with protein translation company Anima

Eli Lilly and Co. (NYSE:LLY) partnered with Anima Biotech Inc. (Bernardsville, N.J.) to discover and develop translation inhibitors against undisclosed targets chosen by Lilly using Anima's Translation Control Therapeutics platform. Anima and Lilly did not...
21:27 , Jul 23, 2018 |  BC Extra  |  Company News

Lilly pairs up with protein translation company Anima

Eli Lilly and Co. (NYSE:LLY) partnered with Anima Biotech Inc. (Bernardsville, N.J.) to discover and develop translation inhibitors against undisclosed targets chosen by Lilly using Anima's Translation Control Therapeutics platform. Anima and Lilly did not...